﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Parathyroid Disease</JournalTitle>
      <Issn>2345-6558</Issn>
      <Volume>3</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2015</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Association between serum magnesium levels with lipids profile in patients undergoing peritoneal dialysis and hemodialysis</ArticleTitle>
    <FirstPage>30</FirstPage>
    <LastPage>33</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Houshang</FirstName>
        <LastName>Sanadgol</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad-Reza</FirstName>
        <LastName>Tamadon</LastName>
      </Author>
      <Author>
        <FirstName>Dadkhoda</FirstName>
        <LastName>Allahsoufi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Introduction: Dyslipidemia, is one of the major causes of cardiovascular disease in dialysis patients. Objectives: This investigation sought to assess the association of serum magnesium level and blood lipids profile in patients under peritoneal dialysis and hemodialysis. Patients and Methods: This cross-sectional investigation was conducted on 110 dialysis patients. Serum lipids and magnesium levels were assessed. Data were analyzed using t-test and Pearson’s correlation. Results: The mean patients’ age was 46.1±14.7 years. In peritoneal dialysis patients, who were not under treatment of antilipid drugs, the correlation of serum magnesium with triglyceride and VLDL was significant (p&lt;0.05), while the association of serum magnesium with total cholesterol and LDL-C was significant, only in subgroup who were under treatment of antilipid drugs (p&lt;0.05). In hemodialysis patients, the correlation of serum magnesium with total cholesterol, triglyceride and VLDL was significant (p&lt;0.05). Conclusions: This study revealed that serum magnesium had correlation with serum lipids and could influence to atherosclerosis and cardiovascular disease in dialysis patients.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Magnesium</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Lipids</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Peritoneal dialysis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hemodialysis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>